CSL – Algo Buy
CSL:ASX 1H21 NPAT of US$1.8bn. FY21 guidance retained at US$2.2bn, which implies a weaker 2H21.
We expect to see earnings upgraded prior to the completion of the 2H.
CSL trades on a forward yield of 1%.

CSL:ASX 1H21 NPAT of US$1.8bn. FY21 guidance retained at US$2.2bn, which implies a weaker 2H21.
We expect to see earnings upgraded prior to the completion of the 2H.
CSL trades on a forward yield of 1%.

CURE:AXW is under Algo Engine buy conditions and the current pullback to $65 provides another buying opportunity.

Coles Group is under Algo Engine buy conditions.
Monitor Coles for a swing higher in the short-term momentum indicators within the $14.50 to $15.50 price range.

Fisher & Paykel Healthcare Corporation is under Algo Engine buy conditions and is now within our highlighted range.
The short-term momentum indicators are now turning higher and it looks like buying support is building near the recent $26 low.

VanEck Vectors China New Economy is under Algo Engine buy conditions and is a current holding in our Global ETF model portfolio.

WPL:ASX has switched to Algo Engine buy conditions.
OPEC and other oil producers will rollover production cuts into April, instead of raising output. This keeps production largely steady, Saudi Arabia continues voluntary cuts.

Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
WPL:ASX has switched to Algo Engine buy conditions.
OPEC and other oil producers will rollover production cuts into April, instead of raising output. This keeps production largely steady, Saudi Arabia continues voluntary cuts.


Xero is under Algo Engine buy conditions and is a current holding in our ASX 100 model.
XRO has announced the proposed acquisition of EU Workforce management platform, Planday. The transaction provides a meaningful step for XRO in accounting expansion in Scandinavia and Continental Europe.

Or start a free thirty day trial for our full service, which includes our ASX Research.